Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 20;11(3):e04261-22. doi: 10.1128/spectrum.04261-22

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Zhao et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

PMC Copyright notice

FIG 1 — Phenotypic and epidemiological characteristics of 416 clinical P. aeruginosa strains collected from 10 tertiary hospitals in Guangdong, China, from 2017 to 2020. (a) Distribution of age of patients from whom the P. aeruginosa strains were recovered. (b) Rate of recovery of P. aeruginosa strains from different clinical departments. (c) Rate of recovery of P. aeruginosa strains from different clinical specimens. (d) Antimicrobial susceptibility of the 416 clinical P. aeruginosa strains. IMP, imipenem; MEM, meropenem; LEV, levofloxacin; AZT, aztreonam; CIP, ciprofloxacin; CAZ, ceftazidime; TZP, piperacillin-tazobactam; FEP, Cefepime; TOB, tobramycin; AMK, amikacin; CST, colistin. Interpretation of resistance phenotypes adheres to the CLSI M100-S26. (e and f) Distribution of the top 10 prevalent ST-types of strains (e) and serotypes (f). The five-pointed star indicates HiRiCs ST-types of strains. (g) Accumulation of pan genes. (h) Number of core genes (99% ≤ strains ≤ 100%) in the 416 P. aeruginosa strains.